Listen to this Episode
Apple PodcastsSpotifyYouTubeGoogle Podcasts
Business Over Chai
E3: Finding a Treatment for COVID-19 with Someit Sidhu of Izana BioScience
Loading
/

In this episode, we speak to Someit Sidhu, founder of Izana Bioscience. Someit studied Medicine at the University of Oxford, and trained as a Medical Doctor at University Hospital Birmingham. Being commercially curious, Someit took up a position as an Associate at McKinsey & Company. He then amalgamated his experiences and co-found Izana Bioscience, a biopharmaceutical company focused on bringing innovative science to market through the development of namilumab for the treatment of Rheumatoid Arthritis. More recently Someit has been investigating the use of namilumab in the treatment of Covid-19.

Someit has just completed the sale of Izana Bioscience and talks about the process in the episode. We also touch on his artistic side of writing poetry and songs which is a passion he shares with his father, who has written popular songs for the Bhangra industry.


Guest Resources
– Izana Bioscience: https://izanabio.com/


Business Over Chai Resources
Our mission is to share startup stories that will inspire the next generation of entrepreneurs across the South Asian community. #businessoverchai


Co-hosts: Andy Paul & Sunny Nagi


– Website: https://www.businessoverchai.com/
– Instagram: https://www.instagram.com/businessoverchai/
– Facebook: https://www.facebook.com/businessoverchai
– LinkedIn: https://www.linkedin.com/company/business-over-chai-podcast
– Twitter: https://twitter.com/bizoverchai
– Linktree: https://linktr.ee/businessoverchai

Give us a review!
If you enjoyed this episode please leave a 5 star review wherever you’re listening! Don’t forget to subscribe and share this podcast with your friends and family!

Disclaimer
The views and opinions expressed in this podcast are of the guest and/or co-hosts and are not representative views held by employers or other related parties.

Listen to this Episode
Apple PodcastsSpotifyYouTubeGoogle Podcasts

Add comment

Your email address will not be published. Required fields are marked *